1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age35-65
SponsorGoldman, Butterwick, Fitzpatrick and Groff

About this trial

To evaluate the efficacy of either a 1550nm non-ablative fractional laser or a 1927nm thulium fractional laser in the treatment of female pattern hair loss (FPHL).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adult women aged 35-65 years

Fitzpatrick skin types I-IV

Presence of female pattern hair loss of the frontal or vertex of scalp (Sinclair (II-IV)

Must be willing and can comply with all study protocols, including all treatment schedules, follow up visit, assessments, sign a photography release and ICF, and complete the entire course of the study

Disqualifiers

No surgery, pregnancy, breast feeding, change in or addition of hormonal contraception in the last 6 months

No history of iron deficiency anemia, vitamin D deficiency, or thyroid disease (hypothyroidism or hyperthyroidism or currently on thyroid supplementation)

Use of scalp light or with laser treatment within the last 6 months.

Use of topical or systemic drugs affecting hair growth within 6 months prior to enrollment (such as oral spironolactone, finasteride, oral or topical minoxidil, and supplements marketed for hair growth such as Nutrafol)

Trial design

Design model

Parallel

Treatments tested in this trial

  • 1550nm non-ablative fractional laser

    Device

    Treatment with the 1550nm non-ablative fractional laser for female pattern hair loss to the frontal and crown of scalp.

  • 1927 thulium fractional laser

    Device

    Treatment with the 1927 thulium fractional laser for female pattern hair loss to the frontal and crown of scalp.

Treatment groups

10 Participants
are divided into 2 treatment groups
Group A: GROUP A 1550nm non-ablative fractional laserExperimental treatment 1 intervention
Group B: GROUP B 1927 thulium fractional laserActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in hair count at a predefined 1cm x 1cm scalp location

Measured by the Canfield Hair Matrix System

Time frame
Baseline and Day 180
2

Change in hair density (hairs/cm) at the same predefined scalp area

Measured by the Canfield Hair Matrix System

Time frame
Baseline and Day 180
3

Change in terminal hair average diameter (in mm) at the predefined location

Measured by the Canfield Hair Matrix System

Time frame
Baseline and Day 180

Secondary outcomes

1

Change in Sinclair Scale score

Sinclair photo grading scale II-IV Grades 1 thru 5 (system would not allow to paste/insert the photo scale)

Time frame
Baseline and Day 180
2

Change in perceived age based on blinded evaluator assessment of global scalp photographs

Estimated age based on posterior scalp evaluation Visit Perceived Age (years)

Time frame
Baseline and Day 180
3

Subjective Assessment on Hair outcomes

Category 1 - No improvement 2 - Slight improvement 3 - Moderate improvement 4 - Noticeable improvement 5 - Significant improvement Hair Density Hair Thickness Hair Growth

Time frame
Day 180
4

Physician Global Aesthetic Improvement Scale (PGAIS) via photos by blinded evaluator

Description Grade Much Improved 2 Improved 1 No Change 0 Worse -1 Much Worse -2

Time frame
Day 180

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: